Skip to Content

G G325 (Indomethacin Extended-Release 75 mg)

Pill with imprint G G325 is Green, Capsule-shape and has been identified as Indomethacin Extended-Release 75 mg. It is supplied by Glenmark Pharmaceuticals Inc., USA.

Indomethacin is used in the treatment of back pain; bursitis; ankylosing spondylitis; bartter syndrome; cluster headaches and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Indomethacin 75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for G G325

Indomethacin extended-release 75 mg G G325

Indomethacin Extended-Release

Imprint
G G325
Strength
75 mg
Color
Green
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Nonsteroidal anti-inflammatory drugs
Pregnancy Category
C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule
Not a controlled drug
Labeler / Supplier
Glenmark Pharmaceuticals Inc., USA
National Drug Code (NDC)
68462-0325
Inactive Ingredients
FD&C Blue No. 1, FD&C Red No. 40, D&C Yellow No. 10, ferrosoferric oxide, lactose monohydrate, polyethylene glycol 4000, potassium hydroxide, shellac, sodium lauryl sulfate, sucrose, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "G G325"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.